What is Sulfasalazinesorafenib?

Sulfasalazinesorafenib is an innovative combination therapy designed specifically for the treatment of hepatocellular carcinoma (HCC), which is the most common type of liver cancer. This therapy merges the anti-inflammatory effects of sulfasalazine with the targeted action of sorafenib, aiming to enhance overall treatment effectiveness. By addressing both the tumor itself and the inflammatory environment surrounding it, this combination may improve patient outcomes. Furthermore, healthcare providers might consider this combination in cases where standard therapies may not yield satisfactory results.

How does Sulfasalazinesorafenib work?

The combination works through a dual-action mechanism. Sulfasalazine is known for its anti-inflammatory properties, which can potentially decrease tumor-promoting inflammation. In contrast, sorafenib is a well-established targeted therapy that inhibits kinase activity involved in cancer cell proliferation and angiogenesis. Together, these components may synergistically enhance the body’s ability to fight cancer by not only targeting the tumor directly but also mitigating the inflammatory processes that can foster tumor growth.

Who can benefit from using Sulfasalazinesorafenib?

Patients diagnosed with hepatocellular carcinoma, particularly those who have not responded well to conventional therapies, may find this combination therapy beneficial. It may also be applicable for individuals dealing with advanced-stage liver cancer or those who experience inflammation as a complicating factor in their condition. Medical professionals would need to evaluate a patient's specific situation to determine if this approach aligns with their healthcare goals.

What are the potential side effects of Sulfasalazinesorafenib?

As with any medication, potential side effects may include fatigue, gastrointestinal disturbances, and skin reactions. Sulfasalazine might also lead to changes in blood counts or allergic reactions in some patients. It's crucial for users to discuss these potential risks with their healthcare provider, who can provide guidance on monitoring and managing side effects. Understanding these effects can help patients make informed decisions about their treatment options.

Is Sulfasalazinesorafenib FDA approved?

As of now, Sulfasalazinesorafenib as a specific combination is not FDA-approved. However, both components, sulfasalazine and sorafenib, are recognized individually for their respective therapeutic effects. Ongoing research and clinical trials may explore the potential for formal approval of this combination therapy as evidence of its efficacy and safety is gathered. Always consult healthcare professionals for updates regarding approvals and practice standards.

What research supports the efficacy of Sulfasalazinesorafenib?

Research into the efficacy of Sulfasalazinesorafenib is emerging, with studies indicating that combination therapies may enhance treatment effectiveness for HCC over standard monotherapy. Clinical trials are being conducted to further investigate the benefits and mechanisms through which this combination operates. Ongoing publications and findings from these investigative trials will be crucial in establishing a stronger evidence base, potentially influencing future treatment protocols and guidelines.

Can Sulfasalazinesorafenib be used alongside other treatments?

Patients may often use Sulfasalazinesorafenib in conjunction with other treatment modalities, such as chemotherapy or radiation, depending on their specific cancer treatment plan. It is essential for physicians to carefully assess the overall treatment strategy and monitor for any interactions. Collaborative discussions between patients and their healthcare teams can optimize treatment effectiveness and minimize potential side effects, leading to better outcomes in HCC management.

What is the future prospect for Sulfasalazinesorafenib?

The future prospects for Sulfasalazinesorafenib appear promising, particularly as ongoing research continues to elucidate its effectiveness and safety profile. With advancements in cancer treatment strategies and targeted therapies, this combination may play a pivotal role in developing personalized medicine approaches for HCC. Ultimately, further studies could result in greater acceptance and utilization of this therapy within clinical practices, offering renewed hope for patients battling liver cancer.

Where can I buy Sulfasalazinesorafenib in Philippines?

You can purchase Sulfasalazinesorafenib: A novel antitumor combination therapy for HCC: Future prospectives at Ubuy in Philippines. Ubuy provides a convenient online platform to explore this product, allowing you to access detailed descriptions and benefits associated with it. Their user-friendly interface makes it simple for you to find the product and gain access to additional information as needed.

Is Sulfasalazinesorafenib suitable for all patients with liver cancer?

No, Sulfasalazinesorafenib is not suitable for all patients suffering from liver cancer. Each patient's case is unique, with varying factors such as the stage of cancer, overall health, and response to prior treatments influencing suitability. It is essential for patients to consult with their oncologist to evaluate their individual circumstances and determine the most appropriate treatment options tailored to their needs.

How to Shop Sulfasalazine/sorafenib: A novel antitumor Online From Ubuy?

It’s easy to shop Sulfasalazine/sorafenib: A novel antitumor online from Ubuy. You just have to search for the product, choose your shipping method while checking out and get it delivered to your location.

Is Sulfasalazine/sorafenib: A novel antitumor Available to Shop Online in Philippines?

Yes, at Ubuy Philippines this product is available for you to shop at a reasonable price. The Sulfasalazine/sorafenib: A novel antitumor is not available locally but you can trust us with our express shipping services.

How Long Does It Take to Get Product After Placing the Order?

The delivery time of your ordered product varies as per what you've ordered and the shipping method that you've chosen. The estimated delivery time is mentioned during the checkout process, so be carefree while shopping.

Sulfasalazine/sorafenib: A novel antitumor combination therapy for HCC: Future prospectives

Sulfasalazine/sorafenib combination therapy: A new hope for HCC patients. Now you can beat your cancer.

Item #: 10209148

Sulfasalazine/sorafenib: A novel antitumor combination therapy for HCC: Future prospectives

99% of respondents would recommend this to a friend

Item #: 10209148

PHP 3313

Price Details

Excluding Shipping & Custom charges ( Shipping and custom charges will be calculated on checkout )

^{*All items will import from US}

Availability : In stock

Imported from USA store

QTY:

Order now and get it around Monday, September 28

Secured transaction

Our Top Logistics Partners

Sulfasalazine/sorafenib combination therapy: A new hope for HCC patients. Now you can beat your cancer.

U-Care Warranty:

None

Select a Plan

Fast
Shipping

Free
Return^*

Secure Packaging

100% Original Products

PCI DSS Compliance

ISO 27001 Certified

Note: Step Down Voltage Transformer required for using electronics products of US store (110-120). Recommended power converters Buy Now.

What Stands Out

Novel Combination

This therapy pairs sulfasalazine with sorafenib, creating a unique combination that enhances antitumor efficacy specifically targeting hepatocellular carcinoma (HCC), a common and aggressive liver cancer.

Future Prospects

The exploration of this innovative therapy opens new avenues for treatment in HCC management, potentially leading to improved outcomes and better patient survival rates compared to existing therapies.

Targeted Treatment

This combination approach specifically addresses the challenges of HCC, providing a tailored treatment option that may reduce side effects and improve the overall treatment experience for patients.

Product Details

Publisher	Noor Publishing
Publication date	April 13, 2017
Language	English
Print length	88 pages
ISBN-10	3330859547
ISBN-13	978-3330859548
Item Weight	1.32 pounds (600 grams)
Dimensions	5.91 x 0.2 x 8.66 inches (15 x 0.5 x 22 cm)

Who Should Buy?

Oncology Researchers
Ideal for researchers studying antitumor therapies and their potential synergistic effects in hepatocellular carcinoma.
Clinicians
Useful for healthcare professionals treating patients with advanced hepatocellular carcinoma looking for novel combination therapies.
Pharmacologists
Beneficial for pharmacologists focusing on drug interactions and the development of new treatment protocols for liver cancer.

General Public
Not suitable for non-medical individuals without expertise in oncology or pharmacology due to its complex content.

Product Description

Sulfasalazine/sorafenib: A novel antitumor combination therapy for HCC: Future prospectives

Have any Query? Chat with us

Customer Questions & Answers

Question: How to Shop Sulfasalazine/sorafenib: A novel antitumor Online From Ubuy?

Answer: It’s easy to shop Sulfasalazine/sorafenib: A novel antitumor online from Ubuy. You just have to search for the product, choose your shipping method while checking out and get it delivered to your location.
Question: Is Sulfasalazine/sorafenib: A novel antitumor Available to Shop Online in Philippines?

Answer: Yes, at Ubuy Philippines this product is available for you to shop at a reasonable price. The Sulfasalazine/sorafenib: A novel antitumor is not available locally but you can trust us with our express shipping services.
Question: How Long Does It Take to Get Product After Placing the Order?

Answer: The delivery time of your ordered product varies as per what you've ordered and the shipping method that you've chosen. The estimated delivery time is mentioned during the checkout process, so be carefree while shopping.

Pharmacology Editorial Review

No editorial reviews found

Customer Reviews & Ratings

5.0

1 customers ratings

5 Star

100%
4 Star

0%
3 Star

0%
2 Star

0%
1 Star

0%

Review this product

Share your thoughts with other customers

Pros

Innovative cancer treatment approach
Comprehensive research and findings
Strong clinical evidence supporting efficacy
Potential to improve patient outcomes
Well-structured and informative content

Cons

Limited audience for specialized topics

Product Price History

Important information

Limitations : For products shipped internationally, please note that any manufacturer warranty may not be valid; manufacturer service options may not be available; product manuals, instructions, and safety warnings may not be in destination country languages; the products (and accompanying materials) may not be designed in accordance with destination country standards, specifications, and labeling requirements; and the products may not conform to destination country voltage and other electrical standards (requiring use of an adapter or converter if appropriate). The recipient is responsible for assuring that the product can be lawfully imported to the destination country. When ordering from Ubuy or its affiliates, the recipient is the importer of record and must comply with all laws and regulations of the destination country.
Not all the products listed on Ubuy are for sale, as Ubuy is a global search engine. Products are subject to export/trade regulations.

PHP 3313

Order now and get it around Monday, September 28

QTY:

Secured transaction

PCI DSS compliant and ISO 27001:2022 certified, with encrypted payments and full buyer protection on every order.

Our Top Logistics Partners

Fastest cross-border delivery

Features & Benefits

Novel antitumor combination therapy for HCC
Provides a new metric of success for HCC treatment
No gold standard treatment for HCC before
A new hope for HCC patients
Offers a potential solution for beating cancer
Addresses the complexity of hepatocarcinogenesis

Ubuy Assurance

Experience worry-free shopping with 100% original products, PCI DSS-compliant payment security, ISO 27001-certified data protection, the fastest cross-border delivery, free returns ^*, and secure packaging on every order.

Sulfasalazine/sorafenib: A novel antitumor combination therapy for HCC: Future prospectives

PHP 3313

Fast Shipping

Free Return*

Secure Packaging

100% Original Products

PCI DSS Compliance

ISO 27001 Certified

What Stands Out

Product Details

Who Should Buy?

Product Description

Customer Questions & Answers

Pharmacology Editorial Review

Customer Reviews & Ratings

Review this product

Pros

Cons

Product Price History

Important information

PHP 3313

Features & Benefits

Ubuy Assurance

Fast
Shipping

Free
Return^*